S. 79 · 118th Congress

Interagency Patent Coordination and Improvement Act of 2023

Introduced on Jan 25, 2023 by Richard J. Durbin (D-IL). 5 cosponsors, 2 of them from another party. Latest action (Mar 1, 2023): Placed on Senate Legislative Calendar under General Orders. Calendar No. 18.

Stage
Reported by committee
Introduced
Jan 25, 2023
Cosponsors
5
2 from the other party
Policy area
Commerce
Open in the Congress explorerCongress.govAlert me

Progress

The furthest stage the measure reached. Simple and concurrent resolutions do not go to the President.

  1. Introduced
  2. Reported by committee
  3. 3Passed one chamber
  4. 4Passed both chambers
  5. 5Sent to the President
  6. 6Became law

Official title

A bill to amend title 35, United States Code, to establish an interagency task force between the United States Patent and Trademark Office and the Food and Drug Administration for purposes of sharing information and providing technical assistance with respect to patents, and for other purposes.

Subjects

  • Administrative remedies
  • Department of Commerce
  • Drug safety, medical device, and laboratory regulation
  • Food and Drug Administration (FDA)
  • Intellectual property
  • Intergovernmental relations

Summary

The Congressional Research Service has not summarized this measure yet.

Sponsor and cosponsors

Cosponsors by party as of the day they signed on. Original cosponsors signed on the day of introduction.

Richard J. DurbinD-ILSponsor

Democrats · 3

Republicans · 2

Roll calls

Recorded votes on the measure. Most measures move by voice vote or unanimous consent, which record no individual positions.

No recorded roll call on this measure: it moved by voice vote or unanimous consent, or has not reached the floor.

History

Every action as published, oldest first. Roll calls link to how each member voted.

  1. Jan 25, 2023Introduced in Senate
  2. Jan 25, 2023 · SenateRead twice and referred to the Committee on the Judiciary.
  3. Feb 9, 2023 · SenateCommittee on the Judiciary. Ordered to be reported without amendment favorably.
  4. Mar 1, 2023Committee on the Judiciary. Reported by Senator Durbin without amendment. Without written report.
  5. Mar 1, 2023 · SenateCommittee on the Judiciary. Reported by Senator Durbin without amendment. Without written report.
  6. Mar 1, 2023 · SenatePlaced on Senate Legislative Calendar under General Orders. Calendar No. 18.

Committees

Committees and subcommittees the measure was referred to.

Agencies in its committees' jurisdiction

Analisa's mapping of committee jurisdiction to federal agencies; the bill may touch others, or none of these.

Who lobbied on it

Organizations whose lobbying reports (LD-2) name this measure. Spending is what they reported for those quarters on all issues, not on this measure alone.

  1. PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA11 reports
    $37.4M reported (all issues)
  2. AMGEN INC.10 reports
    $15.2M reported (all issues)Federal contractor: AMGEN INC.AI match · 99%
  3. PFIZER INC.7 reports
    $2.7M reported (all issues)Federal contractor: PFIZER INCAI match · 100%
  4. AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP)5 reports
    $14.2M reported (all issues)
  5. AMERICAN INTELLECTUAL PROPERTY LAW ASSOCIATION (AIPLA)5 reports
    $10K reported (all issues)
  6. ASSOCIATION FOR CLINICAL ONCOLOGY5 reports
    $1.1M reported (all issues)
  7. Amgen USA, Inc.5 reports
    $300K reported (all issues)Federal contractor: AMGEN USA INC$126M in contracts, FY2026AI match · 100%
  8. BIOTECHNOLOGY INNOVATION ORGANIZATION5 reports
    $8.9M reported (all issues)
  9. Campaign for Sustainable Drug Pricing (CSRxP)5 reports
    $120K reported (all issues)
  10. Chamber of Commerce of the U.S.A.5 reports
    $93.5M reported (all issues)
  11. Fresenius Kabi USA LLC5 reports
    Federal contractor: FRESENIUS KABI USA, LLCAI match · 100%
  12. GENENTECH INC.5 reports
    Federal contractor: GENENTECH USA, INC$939.6K in contracts, FY2026AI match · 100%
  13. GSK (fka GLAXOSMITHKLINE INC.)5 reports
    $6.3M reported (all issues)
  14. JOHNSON & JOHNSON SERVICES, INC.5 reports
    $8.9M reported (all issues)
  15. NATIONAL MULTIPLE SCLEROSIS SOCIETY5 reports
    $319.3K reported (all issues)
  16. NOVARTIS CORPORATION5 reports
    $6.9M reported (all issues)Federal contractor: NOVARTIS PHARMACEUTICALS CORPORATION$36.2M in contracts, FY2026AI match · 100%
  17. Sanofi U.S. Services, Inc.5 reports
    $300K reported (all issues)
  18. The Campaign for Sustainable Rx Pricing5 reports
    $280K reported (all issues)
  19. VIATRIS INC.5 reports
  20. AARP3 reports
    $14.7M reported (all issues)
  21. Families USA Foundation, Inc.2 reports
    $26K reported (all issues)
  22. Justice Action Network2 reports
  23. Public Citizen2 reports
    $134.2K reported (all issues)
  24. The ERISA Industry Committee2 reports
  25. Campaign for Sustainable Drug Pricing1 report
    $30K reported (all issues)
  26. Center for Health and Democracy1 report
    $20K reported (all issues)
  27. New Venture Fund1 report

Reports filed in 2023, 2024.

Sources and method

Every figure on this page traces to these records.

  • Bill status: bills and resolutions, sponsors, actions, subjects and CRS summaries (U.S. Government Publishing Office (GovInfo), from Congress.gov (Library of Congress))GovInfo Bill Status bulk data (Congress.gov; summaries by the Congressional Research Service) · data current to Oct 6, 2026 · loaded Oct 6, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Members of Congress, their terms, committees and identifiers (The @unitedstates project (from the Biographical Directory of the U.S. Congress, the House and the Senate))unitedstates/congress-legislators: legislators, committees and current committee membership · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: CC0 1.0 (public domain dedication)
  • House roll-call votes (Office of the Clerk, U.S. House of Representatives)Office of the Clerk, U.S. House of Representatives, roll-call vote records · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Senate roll-call votes and DW-NOMINATE scores (Voteview (UCLA Department of Political Science))Lewis, Jeffrey B., Keith Poole, Howard Rosenthal, Adam Boche, Aaron Rudkin, and Luke Sonnet (2026). Voteview: Congressional Roll-Call Votes Database. https://voteview.com/ · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Free to use with the required citation
  • Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives)Clerk of the House, Lobbying Disclosure Act filings (organizations only; lobbyists' names are not loaded) · data current to Oct 6, 2026 · loaded Oct 6, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Positions are shown only where a roll call recorded them; voice votes and unanimous consent record none.
  • Money and votes are shown side by side; neither explains the other.